204 related articles for article (PubMed ID: 1448768)
1. Des-gamma-carboxyprothrombin (PIVKA II) and plasma vitamin K1 in newborns and their mothers.
von Kries R; Shearer MJ; Widdershoven J; Motohara K; Umbach G; Göbel U
Thromb Haemost; 1992 Oct; 68(4):383-7. PubMed ID: 1448768
[TBL] [Abstract][Full Text] [Related]
2. Acarboxy prothrombin (PIVKA-II) in cord plasma in the south of Thailand.
Laosombat V; Kenpitak K; Wongchanchailert M; Wiriyasateinkul A
J Med Assoc Thai; 1993 May; 76(5):278-84. PubMed ID: 8006559
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral water soluble vitamin K on PIVKA-II levels in newborns.
Sharma RK; Marwaha N; Kumar P; Narang A
Indian Pediatr; 1995 Aug; 32(8):863-7. PubMed ID: 8635828
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of subclinical vitamin K deficiency in Thai newborns: relationship to maternal phylloquinone intakes and delivery risk.
Chuansumrit A; Plueksacheeva T; Hanpinitsak S; Sangwarn S; Chatvutinun S; Suthutvoravut U; Herabutya Y; Shearer MJ
Arch Dis Child Fetal Neonatal Ed; 2010 Mar; 95(2):F104-8. PubMed ID: 19822527
[TBL] [Abstract][Full Text] [Related]
5. The effects of vitamin K on the generation of des-gamma-carboxy prothrombin (PIVKA-II) in patients with hepatocellular carcinoma.
Sakon M; Monden M; Gotoh M; Kobayashi K; Kanai T; Umeshita K; Endoh W; Mori T
Am J Gastroenterol; 1991 Mar; 86(3):339-45. PubMed ID: 1705389
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of subclinical vitamin K deficiency in cholestatic liver disease.
Strople J; Lovell G; Heubi J
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):78-84. PubMed ID: 19502999
[TBL] [Abstract][Full Text] [Related]
7. Des-gamma-carboxyprothrombin (PIVKA-II) levels in maternal serum throughout gestation.
Nishiguchi T; Matsuyama K; Kobayashi T; Kanayama N
Semin Thromb Hemost; 2005 Jun; 31(3):351-5. PubMed ID: 16052408
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of plasma PIVKA-II as a new marker for hepatocellular carcinoma].
Tada H; Kagawa K; Hikita H; Takeuchi T; Ohta Y; Fukui S; Shintani H; Deguchi T; Okanoue T; Takino T
Gan No Rinsho; 1989 Apr; 35(5):564-70. PubMed ID: 2469809
[TBL] [Abstract][Full Text] [Related]
9. Evidence of vitamin K deficiency in cord blood.
Mahasandana C; Pung-amritt P; Yodthong S; Suvatte V
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():116-20. PubMed ID: 7886551
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of various forms of vitamin-K prophylaxis in breastfed infants].
Cornelissen EA; Monnens LA
Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2205-8. PubMed ID: 8247166
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of a new monoclonal antibody (19B7) against PIVKA-II in the diagnosis of hepatocellular carcinoma and pancreatobiliary malignancies.
Nakao A; Taniguchi K; Inoue S; Takeda S; Harada A; Nonami T; Watanabe K; Takagi H
Am J Gastroenterol; 1997 Jun; 92(6):1031-4. PubMed ID: 9177525
[TBL] [Abstract][Full Text] [Related]
12. PIVKA-II plasma levels as markers of subclinical vitamin K deficiency in term infants.
Dituri F; Buonocore G; Pietravalle A; Naddeo F; Cortesi M; Pasqualetti P; Tataranno ML; Agostino R
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1660-3. PubMed ID: 22280352
[TBL] [Abstract][Full Text] [Related]
13. Effects of oral and intramuscular vitamin K prophylaxis on PIVKA-II assay parameters in breastfed infants in Turkey.
Uluşahin N; Arsan S; Ertogan F
Turk J Pediatr; 1996; 38(3):295-300. PubMed ID: 8827897
[TBL] [Abstract][Full Text] [Related]
14. [Effect of oral and intramuscular vitamin K on the factors II, VII, IX, X, and PIVKA II in the infant newborn under 60 days of age].
Arteaga-Vizcaíno M; Espinoza Holguín M; Torres Guerra E; Diez-Ewald M; Quintero J; Vizcaíno G; Estévez J; Fernández N
Rev Med Chil; 2001 Oct; 129(10):1121-9. PubMed ID: 11775338
[TBL] [Abstract][Full Text] [Related]
15. Precursor prothrombin status in two mother-infant pairs following gestational anticonvulsant therapy.
Argent AC; Rothberg AD; Pienaar N
Pediatr Pharmacol (New York); 1984; 4(3):183-7. PubMed ID: 6493841
[TBL] [Abstract][Full Text] [Related]
16. [Clinical usefulness of plasma PIVKA-II assay and its limitations in patients with hepatocellular carcinoma].
Fujiyama S; Morishita T; Shibata J; Sato T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1129-38. PubMed ID: 2471453
[TBL] [Abstract][Full Text] [Related]
17. Vitamin K1 versus vitamin K3 for prevention of subclinical vitamin deficiency: a randomized controlled trial.
Chawla D; Deorari AK; Saxena R; Paul VK; Agarwal R; Biswas A; Meena A
Indian Pediatr; 2007 Nov; 44(11):817-22. PubMed ID: 18057477
[TBL] [Abstract][Full Text] [Related]
18. PIVKA-II (protein induced by vitamin K absence-II) status in newborns exposed to anticonvulsant drugs in utero.
Anai T; Hirota Y; Oga M; Yoshimatsu J; Miyakawa I
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):347-50. PubMed ID: 2045704
[TBL] [Abstract][Full Text] [Related]
19. Plasma vitamin K1 and PIVKA-II after oral administration of mixed-micellar or cremophor EL-solubilized preparations of vitamin K1 to normal breast-fed newborns.
Schubiger G; Grüter J; Shearer MJ
J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):280-4. PubMed ID: 9138173
[TBL] [Abstract][Full Text] [Related]
20. Relationship of milk intake and vitamin K supplementation to vitamin K status in newborns.
Motohara K; Matsukane I; Endo F; Kiyota Y; Matsuda I
Pediatrics; 1989 Jul; 84(1):90-3. PubMed ID: 2740181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
